But we will also here think about a value-based approach in our pricing and negotiations with the PBMs.

Source: https://seekingalpha.com/article/4650806-eli-lilly-and-company-lly-presents-ubs-biopharma-2023-conference-transcript?source=feed_all_articles

In June 2022, the FTC opened an into six large PBMs: CVS Caremark, Express Scripts, OptumRx, Humana, Prime Therapeutics, and MedImpact Healthcare Systems.

Source: https://www.forbes.com/sites/joshuacohen/2023/04/02/pharmacy-benefit-managers-are-again-in-the-crosshairs-of-congress-and-the-ftc-action-to-reform-drug-pricing-increasingly-likely/

One of the major PBMs lifted the new-to-market block and requires only a single step edit to topical or vitamin D. Another major PBM added us to formulary and requires a step from 2, either through topical steroid vitamin D or combination.

Source: https://seekingalpha.com/article/4577881-roivant-sciences-ltd-roiv-q3-2022-earnings-call-transcript?source=feed_all_articles

On paper PBMs make perfect sense.

Source: https://qz.com/the-price-of-humiras-biosimilars-can-uncloak-the-secret-1850225976

PBMs essentially dictate to pharmacies the amount of payment the pharmacy will receive for prescription drugs that the pharmacy dispenses to patients.

Source: https://krdo.com/news/2023/12/13/opinion-why-your-chain-store-pharmacist-is-so-unhappy/

PBMs have been nothing but a blessing for my former constituents.

Source: https://triblive.com/opinion/ryan-costello-pharmacy-benefit-managers-help-keep-drug-costs-down/

PBMs’ political opponents, such as lobbyists for drugmakers and their allies like the National Community Pharmacists Association, have generated plenty of negative press for PBMs.

Source: https://spectator.org/pharmacy-benefit-managers-are-politicians-next-health-care-scapegoat/

The lawsuit alleges that instead of using such leverage to negotiate lower prices for their customers, PBMs have sought to increase their own profits by raising insulin prices.

Source: https://www.lanereport.com/166914/2023/08/attorney-general-sues-pharmacy-benefit-managers-for-insulin-pricing-scheme/

Three PBMs -- CVS Health Corp (CVS.N), Cigna Group's (CI.N) Express Scripts and UnitedHealth Group's (UNH.N) Optum RX -- together control 80% of the U.S. prescription drug market.

Source: https://www.marketscreener.com/quote/stock/ORGANON-CO-122796891/news/Organon-Samsung-Bioepis-launch-copycat-for-athritis-drug-Humira-at-85-discount-44248207/?utm_medium=RSS&utm_content=20230701

Unfortunately for patients, insurance companies and PBMs often do not pass along the discounted price and instead <em>the patient pays based on the list price of the drug.

Source: https://www.minnpost.com/community-voices/2023/04/the-devil-is-in-the-details-the-truth-behind-minnesotas-prescription-drug-legislation/